BillionToOne 🇺🇸
Round
About BillionToOne
BillionToOne offers a proprietary molecular counting platform that utilizes Quantitative Counting Templates (QCTs™) to measure sparse disease-causing DNA fragments at the single base-pair level, enabling enhanced prenatal screening and liquid biopsy applications. Their technology leverages cell-free DNA to quantify minute genetic variations, facilitating accurate disease detection and therapy monitoring.
BillionToOne is a US-based company founded in 2016, now around 850 people.
Founder: Oguzhan Atay, Phd (Co-founder and CEO; Stanford University).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Want the latest on BillionToOne? Our research agent pulls the current
description, latest round and full investor base from public sources (about a minute).
Round
- Hummingbird Ventures — Hummingbird Ventures was founded in Antwerp and is now based in London. · cheques £500k – £10M
- e2vc — e2vc is an early-stage VC firm. · cheques up to £780k